Which has grown faster, BAX or BIO?

Over the past five years, BIO grew revenue faster — BAX at a -0.86% CAGR versus BIO at -0.84%.

Does BAX or BIO pay a bigger dividend?

BAX pays a dividend (0.96% yield) while BIO does not currently pay one.

Is BAX or BIO more profitable?

BIO runs the higher net margin — BAX at -9.70% versus BIO at 6.52%.

Which has been the better investment, BAX or BIO?

Over the past 10-year, BIO delivered the higher annualized total return — BAX at -5.83% versus BIO at 6.91%. Past performance doesn't predict future results.

Baxter International Inc. (BAX) vs Bio-Rad Laboratories, Inc. (BIO)

BIO leads on 10 of 14 compared metrics.

A side-by-side comparison of Baxter International Inc. and Bio-Rad Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BAX

Baxter International Inc.

$10.77B

$20.86Healthcare

BIO

Bio-Rad Laboratories, Inc.

$7.73B

$285.94Healthcare

Total return — BAX vs BIO

growth of $100 · last 30y

BAX +70.8%BIO +1488.6%BIO compounded faster

Log scale — wide-divergence pair

BAX BIO

BAX vs BIO: by the numbers

•BAX is the larger company ($10.77B vs $7.73B market cap).
•BIO is profitable (6.52% net margin) while BAX runs a net loss (-9.70%).
•BAX pays a dividend (0.96% yield) while BIO does not currently pay one.

Which is better, BAX or BIO?

Metric tally: BAX 4 · BIO 10

It depends on what you're optimizing for:

GrowthBIO(faster 5Y revenue CAGR)

QualityBIO(higher ROIC)

Valuation

Metric	BAX	BIO
P/E ratio	—	47.11
Forward P/E	10.86●	28.69
P/S ratio	0.95●	2.98
P/B ratio	1.78	1.13●
EV / EBITDA	24.95	18.27●
FCF yield	6.64%●	4.63%

Profitability

Metric	BAX	BIO
Gross margin	30.11%	51.87%●
Operating margin	-2.65%	9.25%●
Net margin	-9.70%	6.52%●
ROE	-18.17%	2.46%●
ROIC	-1.79%	2.04%●

Dividends

Metric	BAX	BIO
Dividend yield	0.96%	—

Growth (annualized)

Metric	BAX	BIO
Revenue CAGR (5Y)	-0.86%	-0.84%●
EPS CAGR (5Y)	11.55%●	-26.27%
FCF CAGR (5Y)	-10.81%	-7.57%●
Total return CAGR (5Y)	-22.43%	-13.82%●

Frequently asked

Which is better, BAX or BIO?: It depends on your goal. growth: BIO (faster 5Y revenue CAGR); quality: BIO (higher ROIC). Across all compared metrics, BIO leads 10 to 4.
Which has grown faster, BAX or BIO?: Over the past five years, BIO grew revenue faster — BAX at a -0.86% CAGR versus BIO at -0.84%.
Does BAX or BIO pay a bigger dividend?: BAX pays a dividend (0.96% yield) while BIO does not currently pay one.
Is BAX or BIO more profitable?: BIO runs the higher net margin — BAX at -9.70% versus BIO at 6.52%.
Which has been the better investment, BAX or BIO?: Over the past 10-year, BIO delivered the higher annualized total return — BAX at -5.83% versus BIO at 6.91%. Past performance doesn't predict future results.

Go deeper

Full BAX analysis Full BIO analysis Interactive comparison tool

Dig into the metrics

Baxter International P/E ratio Bio-Rad Laboratories P/E ratio Baxter International dividend yield Bio-Rad Laboratories dividend yield Baxter International ROE Bio-Rad Laboratories ROE Baxter International operating margin Bio-Rad Laboratories operating margin Baxter International revenue growth Bio-Rad Laboratories revenue growth Baxter International free cash flow Bio-Rad Laboratories free cash flow

Baxter International & Bio-Rad Laboratories appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.